Skip to main content
Lu Lin, MD, Neurology, Houston, TX

Lu Lin MD , PhD

Epilepsy, Neurophysiology


Physician

Join to View Full Profile
  • 7200 Cambridge StSte 9AHouston, TX 77030

  • Phone+1 713-798-2273

  • Fax+1 713-798-7561

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women’s Hospital/Children’s Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women’s Hospital/Children’s Hospital/Harvard Medical SchoolFellowship, Epilepsy, 2017 - 2018
  • Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical School
    Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 2016 - 2017
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2012 - 2016
  • Beijing Medical University
    Beijing Medical UniversityClass of 2003

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2026
  • MA State Medical License
    MA State Medical License 2016 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Clinical Neurophysiology
    American Board of Psychiatry and Neurology Clinical Neurophysiology
  • Epilepsy
    American Board of Psychiatry and Neurology Epilepsy

Publications & Presentations

PubMed

Press Mentions

  • COVID-19-Associated Seizures May Be Common, Linked to Higher Risk of Death
    COVID-19-Associated Seizures May Be Common, Linked to Higher Risk of DeathApril 16th, 2021
  • Study of COX-2 Inhibitors Could Lead to New Class of Stroke Drugs
    Study of COX-2 Inhibitors Could Lead to New Class of Stroke DrugsOctober 4th, 2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: